Europe’s medicines regulator calls for recall of Biogen, AbbVie multiple sclerosis drug

(Reuters) – Europe’s medicines regulator recommended the immediate suspension and recall of Biogen Inc and AbbVie Inc’s multiple sclerosis drug Zinbryta, following 12 reports of inflammation of the brain, three of which cases were fatal.

This post was syndicated from Reuters: Health News. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply